| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |